Form 8-K - Current report:
SEC Accession No. 0001213900-25-013498
Filing Date
2025-02-13
Accepted
2025-02-13 16:11:46
Documents
16
Period of Report
2025-02-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0230563-8k425_bellevue.htm   iXBRL 8-K 75693
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ea023056301ex3-1_bellevue.htm EX-3.1 34101
3 PRESS RELEASE, DATED FEBRUARY 13, 2025 ea023056301ex99-1_bellevue.htm EX-99.1 13400
  Complete submission text file 0001213900-25-013498.txt   378105

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE blac-20250213.xsd EX-101.SCH 4416
5 XBRL DEFINITION FILE blac-20250213_def.xml EX-101.DEF 27730
6 XBRL LABEL FILE blac-20250213_lab.xml EX-101.LAB 38554
7 XBRL PRESENTATION FILE blac-20250213_pre.xml EX-101.PRE 26346
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0230563-8k425_bellevue_htm.xml XML 8747
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 25620372
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)